ChanTest Corporation Signs Research Collaboration Agreement with The FDA

6/9/2011 8:50:58 AM

MORRISVILE, N.C.--(BUSINESS WIRE)--TearScience, Inc., a privately-held medical device company, today announced the product launch of its LipiView® Ocular Surface Interferometer and LipiFlow® Thermal Pulsation medical devices in Canada. TearScience’s devices were designed to help eye care physicians address a root cause of evaporative dry eye, Meibomian Gland Dysfunction (MGD), which results in a lipid deficiency of the eye’s natural tear film. LipiView® helps physicians visualize the eye’s natural tear film. LipiFlow® is designed to alleviate meibomian gland obstructions by applying a precise combination of directed energy to eyelids during a 12 minute in-office treatment.

Read at BioSpace.com

Read Article at

Related Companies

News Categories

• BioSpace.com

• Food and Drug Administration (FDA)

• ChanTest Corporation

• Diagnostics

• Medical Dev. & Diag. - Alliances